Home > Insider Trading > Filing (0001144204-13-067451)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313149	W Steven Lefkowitz	C/O Cormedix Inc. 745 Route 202-206, Suite 303 Bridgewater NJ US 08807	Interim Chief Financial Ofcr	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	Acquisiton	2013-12-16	7,500	$0.74	141,929	No	4	P	Direct
Common Stock, $0.001 Par Value Per Share	Acquisiton	2013-12-13	10,500	$0.80	134,429	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, $0.001 Par Value Per Share	Senior Convertible Note (convertible into Common Stock)	Disposition	2013-11-13	42,857	$0.35	42,857	$0.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-11-13	2013-11-13	No	4	C	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value Per Share	100,000	Indirect	Wade Capital Corporation Money Purchase Plan
Common Stock, $0.01 Par Value Per Share	1,000	Indirect	Report Person's Wife

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, $0.001 Par Value Per Share	Warrant (right to purchase Common Stock)	$3.44	2013-08-20	2015-03-24	5,000	5,000	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$0.90		2023-03-20	120,000	120,000	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$0.68		2022-12-05	150,000	150,000	Direct
Common Stock, $0.001 Par Value Per Share	Warrant (right to purchase Common Stock)	$0.40	2012-11-13	2017-11-13	37,500	37,500	Direct
Common Stock, $0.001 Par Value Per Share	Warrant (right to purchase Common Stock)	$0.40	2012-09-20	2017-09-20	87,500	87,500	Indirect
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$0.29		2022-01-06	30,000	30,000	Direct
Common Stock, $0.001 Par Value Per Share	Stock Option (right to buy)	$1.10		2021-08-11	30,000	30,000	Direct
Common Stock, $0.001 Par Value Per Share	Warrant	$3.44		2015-03-24	19,536	19,536	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-03-24	5,000	5,000	Direct
2023-03-20	120,000	120,000	Direct
2022-12-05	150,000	150,000	Direct
2017-11-13	37,500	37,500	Direct
2017-09-20	87,500	87,500	Indirect
2022-01-06	30,000	30,000	Direct
2021-08-11	30,000	30,000	Direct
2015-03-24	19,536	19,536	Direct

Footnotes

The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
These options vest quarterly over two years beginning June 13, 2013.
These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification for Neutrolin in Europe, which occuured on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.
The options vest in full on the first anniversary of the date of grant.
The options vest ratably, one-third of which will vest on each of the grant date, the first anniversary and the second anniversary thereof.
(Right to buy Common Stock, $0.001 par value per share)
The warrants were issued as part of the Company's initial public offering in March 2010 and were exercisable beginning six months after the effective date of the Company's registration statement related thereto.
The reporting person's Form 4 filed September 23, 2013 mistakenly indicated the total number of securities beneficially owned was 181,072, when in fact the total number of securities beneficially owned is 100,000.